Jak3 maps to chromosome 8

被引:6
|
作者
Kono, DH
Owens, DG
Wechsler, AR
机构
[1] Department of Immunology/IMM3, Scripps Research Institute, San Diego, CA 92037
关键词
D O I
10.1007/s003359900145
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:476 / 477
页数:2
相关论文
共 50 条
  • [1] JAK3 maps to human chromosome 19p12 within a cluster of protooncogenes and transcription factors
    Hoffman, SMG
    Lai, KS
    Tomfohrde, J
    Bowcock, A
    Gordon, LA
    Mohrenweiser, HW
    GENOMICS, 1997, 43 (01) : 109 - 111
  • [2] Design of JAK3 covalent inhibitors for the interrogation of JAK3 signaling in humans
    Casimiro-Garcia, Agustin
    Thorarensen, Atli
    Telliez, Jean-Baptiste
    Balbo, Paul
    Banker, Mary
    Brown, Matthew
    Che, Ye
    Chrencik, Jill
    Coe, Jotham
    Czerwinski, Robert
    Dowty, Martin
    Gilbert, Adam
    Hayward, Matthew
    Hegen, Martin
    Juba, Brian
    Jussif, Jason
    Langille, Jonathan
    Leung, Louis
    Liang, Sidney
    Lin, Tsung
    Montgomery, Justin
    Soucy, Sarah
    Trujillo, John
    Unwalla, Ray
    Vajdos, Felix
    Vincent, Fabien
    Yang, Xin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [3] MUTATION OF JAK3 IN A PATIENT WITH SCID - ESSENTIAL ROLE OF JAK3 IN LYMPHOID DEVELOPMENT
    RUSSELL, SM
    TAYEBI, N
    NAKAJIMA, H
    RIEDY, MC
    ROBERTS, JL
    AMAN, MJ
    MIGONE, TS
    NOGUCHI, M
    MARKERT, ML
    BUCKLEY, RH
    O'SHEA, JJ
    LEONARD, WJ
    SCIENCE, 1995, 270 (5237) : 797 - 800
  • [4] JAK3 Variants in Adults with Myeloid Malignancies and Potential for Response to JAK3 Inhibition
    Assi, Rita
    Benton, Christopher B.
    Al Rawi, Ahmed
    Chamoun, Kamal
    Wang, Feng
    Pierce, Sherry
    Patel, Keyur P.
    Hamilton, Betty K.
    DiNardo, Courtney D.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Kadia, Tapan
    Verstovsek, Srdan
    Andreeff, Michael
    BLOOD, 2017, 130
  • [5] Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL
    Degryse, Sandrine
    Bornschein, Simon
    de Bock, Charles E.
    Leroy, Emilie
    Vanden Bempt, Marlies
    Demeyer, Sofie
    Jacobs, Kris
    Geerdens, Ellen
    Gielen, Olga
    Soulier, Jean
    Harrison, Christine J.
    Constantinescu, Stefan N.
    Cools, Jan
    BLOOD, 2018, 131 (04) : 421 - 425
  • [6] JAK3: Expression and mapping to chromosome 19p12-13.1
    Safford, MG
    Levenstein, M
    Tsifrina, E
    Amin, S
    Hawkins, AL
    Griffin, CA
    Civin, CI
    Small, D
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (05) : 374 - 386
  • [7] JAK3 inhibition—is it sufficient?
    Warren J Leonard
    Suman Mitra
    Jian-Xin Lin
    Nature Chemical Biology, 2016, 12 : 308 - 310
  • [8] Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
    Elwood, Fiona
    Witter, David J.
    Piesvaux, Jennifer
    Kraybill, Brian
    Bays, Nathan
    Alpert, Carla
    Goldenblatt, Peter
    Qu, Yujie
    Ivanovska, Irena
    Lee, Hyun-Hee
    Chiu, Chi-Sung
    Tang, Hao
    Scott, Mark E.
    Deshmukh, Sujal V.
    Zielstorff, Mark
    Byford, Alan
    Chakravarthy, Kalyan
    Dorosh, Lauren
    Rivkin, Alexey
    Klappenbach, Joel
    Pan, Bo-Sheng
    Kariv, Ilona
    Dinsmore, Christopher
    Slipetz, Deborah
    Dandliker, Peter J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (02): : 229 - 244
  • [9] JAK3 SCID: Mutations in noncatalytic domain and basis of Jak3 gamma c interaction.
    Chen, M
    Candotti, F
    Oakes, SA
    Vezzoni, P
    Blaese, RM
    Notarangelo, LD
    Villa, A
    OShea, JJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1929 - 1929
  • [10] Role of Jak3 in chronic myeloid leukemia: Evidence to identify Jak3 as a potential therapeutic target
    Lin, Q
    Prudkin, ML
    Kantarjian, HM
    Cortes, JE
    Lau, E
    Grammatikakis, I
    Thomazy, VA
    Lai, R
    Amin, HM
    BLOOD, 2005, 106 (11) : 804A - 805A